Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Treace Medical Concepts Q2 EPS $(0.28) Beats $(0.29) Estimate, Sales $47.387M Beat $47.077M Estimate

Author: Benzinga Newsdesk | August 07, 2025 03:06pm
Treace Medical Concepts (NASDAQ:TMCI) reported quarterly losses of $(0.28) per share which beat the analyst consensus estimate of $(0.29) by 2.78 percent. This is a 17.65 percent increase over losses of $(0.34) per share from the same period last year. The company reported quarterly sales of $47.387 million which beat the analyst consensus estimate of $47.077 million by 0.66 percent. This is a 6.60 percent increase over sales of $44.455 million the same period last year.

Posted In: TMCI


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist